Spago Nanomedical AB (publ)
Healthcare
SPAGO.ST:
Research by ALPHA
Author: Alpha
- 0.22 +14.87% (25/03/2025)
- MONITOR
Spago Nanomedical is an early stage Biotech startup developing nano-materials as contrast fluid for MR scans to improve detection of cancer. At the current Phase I/IIa the company is pre-revenue and a high-risk investment.
04/03/2025| Analyses:0
0